Covenant Health has announced the launch of CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center (JACC) ...

During a Q2 earnings call, the firm discussed progress on an FGFR2b antibody, a subcutaneous version of Blincyto, and ...

Mutations in a single gene, HNF1A, are known to cause MODY3, a rare, early-onset form of diabetes. Smaller-scale mutations in ...

The virus is already known to raise the risk of six types of cancer, including anal, head and neck, throat and a number of ...

Mutations in a single gene, HNF1A, are known to cause MODY3, a rare, early onset form of diabetes. Smaller scale mutations in the very same gene are ...

Maharashtra CET Cell is set to release today i.e. Tuesday August 05, 2025 on its official website dse2025.mahacet.org.in ...

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates and BNT327, a bispecific antib ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development ...